EVOK EVOKE PHARMA INC Management Changes 8-K Filing 2024 - Appointment of CFO, Salary Increase for CEO, Amendments to Equity Incentive Plan and Certificate of Incorporation Evoke Pharma Inc appointed Mark A. Kowieski as Chief Financial Officer, increased CEO Matthew J. D Onofrio's base salary and target bonus, and approved amendments to the company's Equity Incentive Award Plan and Certificate of Incorporation.Get access to all SEC 8-K filings of the EVOKE PHARMA INC